Skip to Content
Merck
CN

Fixed-combination topical anti-hypertensive ophthalmic agents.

Expert opinion on pharmacotherapy (2020-04-02)
Lindsay Machen, Reza Razeghinejad, Jonathan S Myers
ABSTRACT

Fixed-combination glaucoma medications have altered the paradigm of ocular hypertension and glaucoma treatment and are in widespread use today. A comprehensive review of fixed-combination medications will help educate and inform providers for optimal patient care. In this review, the authors describe the composition, mechanism of action, efficacy, side effects, and safety profile of fixed-combination agents for the treatment of ocular hypertension and glaucoma as well as comparisons between the most frequently prescribed medications. Fixed-combination therapeutics provide an effective and efficient means of lowering intraocular pressure with comparable side effects and outcomes to constituent parts with lower patient exposure to preservatives and improvement in compliance.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
17-Phenyl-tri-norprostaglandin F-ethyl amide, ≥95%, solid